GAMMA Investing’s Humacyte HUMA Stock Holding History

GAMMA Investing’s Portfolio HUMA Stock Details HUMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-243	Closed	-$190	–	4363
2026 Q2	$190	Sell	243 -3,459	-93%	-$3.21K	﹤0.01%	4097
2026 Q1	$2.25K	Buy	3,702 +2,313	+167%	+$2.4K	﹤0.01%	3639
2025 Q4	$1.33K	Buy	+1,389	New	+$1.97K	﹤0.01%	3717
2025 Q1	–	Sell	-112	Closed	-$566	–	3833
2024 Q4	$566	Sell	112 -117	-51%	-$579	﹤0.01%	3554
2024 Q3	$1.25K	Buy	229 +71	+45%	+$468	﹤0.01%	3198
2024 Q2	$758	Buy	158 +46	+41%	+$239	﹤0.01%	3120
2024 Q1	$348	Hold	112	–	–	﹤0.01%	3157
2023 Q4	$372	Buy	+112	New	+$287	﹤0.01%	3019

Other funds holding HUMA

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

AWM

Act Wealth Management Plano, Texas $340M AUM 15.43% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's HUMA Position: Q3 2026 in Review

GAMMA Investing sold out of Humacyte (HUMA) in Q3 2026, closing a stake of 243 shares — an estimated $190 sold.

GAMMA Investing first reported a position in HUMA in Q4 2023 and held it in 8 quarters. The position peaked at $2.25K in Q1 2026. 5 funds tracked by Wall St. Rank hold HUMA as of Q3 2026.

GAMMA Investing reported no remaining Humacyte position as of Q3 2026 after selling out during the quarter.
GAMMA Investing sold 243 Humacyte shares in Q3 2026, an estimated $190.
GAMMA Investing first reported a position in Humacyte in Q4 2023 and held it in 8 quarters.
GAMMA Investing's Humacyte position peaked at $2.25K in Q1 2026.
5 funds tracked by Wall St. Rank held Humacyte as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.